Skip to content

Dietary guidance and walking exercise therapy for patients with psychotic disorders: an open-label study

Dietary guidance and walking exercise therapy for patients with psychotic disorders - Dietary guidance and walking exercise therapy for patients with psychotic disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048435
Enrollment
20
Registered
2022-07-22
Start date
2021-02-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic disorders

Interventions

Dietary guidance/Walking exercise therapy

Sponsors

Fujita Health University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients who, after receiving full explanation and with full understanding, give written consent of their own free will to participate in this study 2. patients who are between 20 and 65 years of age at the time of consent 3. patients with clinically stable psychiatric symptoms 4. patients who are capable of performing walking exercise therapy (10,000 steps/day, at least 5 days/week) 5. patients with BMI >25

Exclusion criteria

Exclusion criteria: 1. patients with serious physical illnesses 2. pregnant, lactating or planning to become pregnant 3. patients with blood pressure that is not stabilized due to hypertension of the third degree (blood pressure of 180/100 mg HG or higher) 4. patients with a history of cerebrovascular disease or with signs and symptoms that suggest such a disease 5. patients with suicidal ideation or suicidal attempts 6. patients with signs and symptoms of acute inflammation of the musculoskeletal system in the locomotor area 7. patients with diabetes mellitus 8. other patients who are deemed inappropriate by the Principal Investigator or Principal Investigator

Design outcomes

Primary

MeasureTime frame
Weight and body composition measurement (InBody470)

Secondary

MeasureTime frame
Clinical Global Impressions - severity of illness

Countries

Japan

Contacts

Public ContactKishi Taro

Fujita Health University School of Medicine Psychiatry

tarok@fujita-hu.ac.jp0562939250

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026